Home › Juvenile Myelomonocytic Leukemia › New York › New York City
Juvenile Myelomonocytic Leukemia clinical trials in New York City, NY
3 studies for Juvenile Myelomonocytic Leukemia are looking for participants at sites in and around New York City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia
RecruitingPhase 1/2
- Memorial Sloan Kettering Cancer Center, New York
A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy
RecruitingPhase 1
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RecruitingPhase 1/2
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- Memorial Sloan Kettering Cancer Center, New York
Juvenile Myelomonocytic Leukemia trials in other cities
- Philadelphia, PA4 studies
- Minneapolis, MN4 studies
- Boston, MA3 studies
- Cincinnati, OH3 studies
- Indianapolis, IN3 studies
- Memphis, TN3 studies
- Atlanta, GA3 studies
- Chicago, IL3 studies
- San Francisco, CA3 studies
- Washington, DC3 studies
- Ann Arbor, MI3 studies
- Seattle, WA3 studies
Other studies in New York City
- Breast Cancer136 studies
- Non-Small Cell Lung Cancer121 studies
- Cancer (all types)109 studies
- Prostate Cancer103 studies
- Metastatic Cancer93 studies
- Colorectal Cancer78 studies
- Ovarian Cancer69 studies
- Lung Cancer60 studies
- Multiple Myeloma60 studies
- Pancreatic Cancer60 studies
- Endometrial Cancer52 studies
- Acute Myeloid Leukemia51 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.